DANAHER CORP

Danaher is a global science and technology innovator focused on improving human health. The company operates through more than 15 operating companies, which hold leadership positions in the biotechnology, life sciences, and diagnostics sectors. These businesses are organized into three segments: Biotechnology, Life Sciences, and Diagnostics. Danaher's businesses typically sell a high level of products and services on a recurring basis, primarily through a direct sales model, to a geographically diverse customer base. The company's research and development, manufacturing, sales, distribution, service, and administrative facilities are located in approximately 50 countries. Danaher aims to create shareholder value by strengthening its competitive advantage through the DANAHER BUSINESS SYSTEM ("DBS") tools and culture, enhancing its portfolio in attractive science and technology markets through strategic capital allocation, and consistently attracting and retaining exceptional talent. The company measures its progress against these priorities over the long-term using financial metrics related to revenue growth, profitability, cash flow, and capital returns, as well as certain non-financial metrics. Danaher acquires businesses and makes investments that either complement its existing portfolio or expand into new attractive markets. It also continually assesses the strategic fit of its existing businesses and may separate or dispose of businesses based on strategic and other considerations.